The medical grade liquid nitrogen market size has grown strongly in recent years. It will grow from $2.48 billion in 2025 to $2.64 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to expansion of medical research activities, increasing use of cryotherapy in dermatology, growth in biobanking applications, adoption of liquid nitrogen in pharmaceutical processes, rising demand from fertility clinics.
The medical grade liquid nitrogen market size is expected to see strong growth in the next few years. It will grow to $3.39 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing adoption of regenerative medicine applications, expansion of cell and gene therapy storage needs, rising demand for ultra-high purity nitrogen, growing investments in advanced cryogenic logistics, increasing healthcare infrastructure development. Major trends in the forecast period include increasing use of cryopreservation in healthcare, rising demand for high-purity medical gases, expansion of cold chain and cryogenic storage infrastructure, growing adoption of cryosurgical procedures, enhanced focus on regulatory compliance and traceability.
The growing demand for cryopreservation and cryosurgery in the medical sector is expected to drive the expansion of the medical-grade liquid nitrogen market. These applications involve using extremely low temperatures, primarily through liquid nitrogen, to preserve biological materials or to treat medical conditions by freezing and removing abnormal tissues. The increased use of cryopreservation and cryosurgery is linked to their role in fertility treatments and stem cell banking, with more individuals choosing to preserve reproductive and stem cells for future use due to medical conditions, personal choices, or advancements in regenerative medicine. Medical-grade liquid nitrogen supports these applications by offering a high-purity cryogenic solution essential for maintaining biological viability and enabling precise cryosurgical interventions. For example, in June 2024, Vitality Pro, a UK-based health and wellness company, reported that around 500 individuals globally have undergone cryonic preservation, with another 4,000 registered for future procedures, indicating growing interest in this emerging technology. Consequently, rising demand in cryopreservation and cryosurgery is fueling the growth of the medical-grade liquid nitrogen market.
Leading companies in the medical-grade liquid nitrogen market are introducing cutting-edge technologies such as liquid nitrogen cryotherapy devices to address chronic respiratory conditions through minimally invasive treatments. These devices utilize extremely cold liquid nitrogen to freeze and eliminate abnormal or damaged tissue, serving therapeutic purposes such as treating warts, precancerous lesions, and skin conditions. For instance, in July 2024, CSA Medical Inc., a US-based medical device manufacturer, completed patient enrollment in its SPRAY-CB trial for the RejuvenAir System, an innovative cryotherapy device. This system delivers targeted liquid nitrogen spray to treat chronic bronchitis by applying cold temperatures to damaged lung cells. The outpatient procedure promotes regenerative healing without causing scarring and represents a significant advancement in chronic obstructive pulmonary disease (COPD) treatment by addressing mucus overproduction and airway damage.
In January 2023, Linde plc, a UK/Ireland-based global industrial gases and engineering company, acquired nexAir, LLC for an undisclosed amount. Through this acquisition, Linde obtained full (100%) ownership of nexAir, consolidating its packaged gas distribution network in the United States and reinforcing its supply chain for gases, including medical-grade liquid nitrogen. nexAir, LLC is a U.S.-based independent packaged gas distributor serving industrial, healthcare, and welding customers.
Major companies operating in the medical grade liquid nitrogen market are Linde Gas & Equipment Inc., Air Liquide Healthcare, Air Products and Chemicals Inc., Airgas Inc., Nippon Sanso Holdings Corporation, Matheson Tri-Gas Inc., Gruppo SIAD, Gulf Cryo, AMCS Corporation, Red Ball Oxygen, MVS Engineering Pvt. Ltd., Coregas Pty Ltd., Kansal Industrial Gases, Stirling Cryogenics, CalOx Inc., US Gas, N-Two Medical Inc., Nitrogen Express, Cryogen (part of the Antares Alliance), Abhijit Enterprises.
North America was the largest region in the medical grade liquid nitrogen market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical grade liquid nitrogen market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical grade liquid nitrogen market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the medical grade liquid nitrogen market by increasing costs of imported cryogenic equipment, storage vessels, transportation containers, and monitoring systems required for safe handling and distribution. Healthcare and research facilities in North America and Europe are most affected due to reliance on imported cryogenic infrastructure, while Asia-Pacific faces higher costs for specialized storage systems. These tariffs are raising operational and logistics expenses for suppliers. However, they are also encouraging domestic production of cryogenic equipment, localized gas processing facilities, and strengthened regional supply chains.
The medical grade liquid nitrogen market research report is one of a series of new reports that provides medical grade liquid nitrogen market statistics, including medical grade liquid nitrogen industry global market size, regional shares, competitors with a medical grade liquid nitrogen market share, detailed medical grade liquid nitrogen market segments, market trends and opportunities, and any further data you may need to thrive in the medical grade liquid nitrogen industry. This medical grade liquid nitrogen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Medical-grade liquid nitrogen is a highly purified cryogenic liquid produced under stringent industry standards to ensure its safety and effectiveness in medical environments. It is widely utilized in healthcare procedures such as cryotherapy for treating skin disorders, cryopreservation for storing biological specimens such as blood and reproductive cells, and as a cooling medium in surgical and research settings. Its manufacturing and distribution involve rigorous quality control measures, guaranteeing full traceability and adherence to regulatory standards to safeguard patient health.
The primary types of medical-grade liquid nitrogen are categorized by purity levels below 99%, between 99% and 99.9%, and above 99.9%. Liquid nitrogen with a purity below 99% is generated by liquefying nitrogen gas at extremely low temperatures and is suitable for specific medical uses such as cryotherapy and tissue preservation. These products are stored in various container formats including dewar flasks, pressurized cylinders, storage tanks, portable cryogenic containers, and bulk liquid nitrogen tanks. Distribution channels include direct sales, online platforms, medical supply distributors, retail pharmacies, and specialized medical suppliers. They are applied in areas such as cryopreservation, cryosurgery, medical laboratories, pharmaceutical processes, and dermatological treatments. End users include hospitals and clinics, biotechnology and pharmaceutical companies, research laboratories, and other healthcare facilities.
The medical grade liquid nitrogen market consists of sales of products such as cryogenic storage tanks, liquid nitrogen dewars, delivery systems, and associated safety equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The medical grade liquid nitrogen market size is expected to see strong growth in the next few years. It will grow to $3.39 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing adoption of regenerative medicine applications, expansion of cell and gene therapy storage needs, rising demand for ultra-high purity nitrogen, growing investments in advanced cryogenic logistics, increasing healthcare infrastructure development. Major trends in the forecast period include increasing use of cryopreservation in healthcare, rising demand for high-purity medical gases, expansion of cold chain and cryogenic storage infrastructure, growing adoption of cryosurgical procedures, enhanced focus on regulatory compliance and traceability.
The growing demand for cryopreservation and cryosurgery in the medical sector is expected to drive the expansion of the medical-grade liquid nitrogen market. These applications involve using extremely low temperatures, primarily through liquid nitrogen, to preserve biological materials or to treat medical conditions by freezing and removing abnormal tissues. The increased use of cryopreservation and cryosurgery is linked to their role in fertility treatments and stem cell banking, with more individuals choosing to preserve reproductive and stem cells for future use due to medical conditions, personal choices, or advancements in regenerative medicine. Medical-grade liquid nitrogen supports these applications by offering a high-purity cryogenic solution essential for maintaining biological viability and enabling precise cryosurgical interventions. For example, in June 2024, Vitality Pro, a UK-based health and wellness company, reported that around 500 individuals globally have undergone cryonic preservation, with another 4,000 registered for future procedures, indicating growing interest in this emerging technology. Consequently, rising demand in cryopreservation and cryosurgery is fueling the growth of the medical-grade liquid nitrogen market.
Leading companies in the medical-grade liquid nitrogen market are introducing cutting-edge technologies such as liquid nitrogen cryotherapy devices to address chronic respiratory conditions through minimally invasive treatments. These devices utilize extremely cold liquid nitrogen to freeze and eliminate abnormal or damaged tissue, serving therapeutic purposes such as treating warts, precancerous lesions, and skin conditions. For instance, in July 2024, CSA Medical Inc., a US-based medical device manufacturer, completed patient enrollment in its SPRAY-CB trial for the RejuvenAir System, an innovative cryotherapy device. This system delivers targeted liquid nitrogen spray to treat chronic bronchitis by applying cold temperatures to damaged lung cells. The outpatient procedure promotes regenerative healing without causing scarring and represents a significant advancement in chronic obstructive pulmonary disease (COPD) treatment by addressing mucus overproduction and airway damage.
In January 2023, Linde plc, a UK/Ireland-based global industrial gases and engineering company, acquired nexAir, LLC for an undisclosed amount. Through this acquisition, Linde obtained full (100%) ownership of nexAir, consolidating its packaged gas distribution network in the United States and reinforcing its supply chain for gases, including medical-grade liquid nitrogen. nexAir, LLC is a U.S.-based independent packaged gas distributor serving industrial, healthcare, and welding customers.
Major companies operating in the medical grade liquid nitrogen market are Linde Gas & Equipment Inc., Air Liquide Healthcare, Air Products and Chemicals Inc., Airgas Inc., Nippon Sanso Holdings Corporation, Matheson Tri-Gas Inc., Gruppo SIAD, Gulf Cryo, AMCS Corporation, Red Ball Oxygen, MVS Engineering Pvt. Ltd., Coregas Pty Ltd., Kansal Industrial Gases, Stirling Cryogenics, CalOx Inc., US Gas, N-Two Medical Inc., Nitrogen Express, Cryogen (part of the Antares Alliance), Abhijit Enterprises.
North America was the largest region in the medical grade liquid nitrogen market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical grade liquid nitrogen market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical grade liquid nitrogen market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the medical grade liquid nitrogen market by increasing costs of imported cryogenic equipment, storage vessels, transportation containers, and monitoring systems required for safe handling and distribution. Healthcare and research facilities in North America and Europe are most affected due to reliance on imported cryogenic infrastructure, while Asia-Pacific faces higher costs for specialized storage systems. These tariffs are raising operational and logistics expenses for suppliers. However, they are also encouraging domestic production of cryogenic equipment, localized gas processing facilities, and strengthened regional supply chains.
The medical grade liquid nitrogen market research report is one of a series of new reports that provides medical grade liquid nitrogen market statistics, including medical grade liquid nitrogen industry global market size, regional shares, competitors with a medical grade liquid nitrogen market share, detailed medical grade liquid nitrogen market segments, market trends and opportunities, and any further data you may need to thrive in the medical grade liquid nitrogen industry. This medical grade liquid nitrogen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Medical-grade liquid nitrogen is a highly purified cryogenic liquid produced under stringent industry standards to ensure its safety and effectiveness in medical environments. It is widely utilized in healthcare procedures such as cryotherapy for treating skin disorders, cryopreservation for storing biological specimens such as blood and reproductive cells, and as a cooling medium in surgical and research settings. Its manufacturing and distribution involve rigorous quality control measures, guaranteeing full traceability and adherence to regulatory standards to safeguard patient health.
The primary types of medical-grade liquid nitrogen are categorized by purity levels below 99%, between 99% and 99.9%, and above 99.9%. Liquid nitrogen with a purity below 99% is generated by liquefying nitrogen gas at extremely low temperatures and is suitable for specific medical uses such as cryotherapy and tissue preservation. These products are stored in various container formats including dewar flasks, pressurized cylinders, storage tanks, portable cryogenic containers, and bulk liquid nitrogen tanks. Distribution channels include direct sales, online platforms, medical supply distributors, retail pharmacies, and specialized medical suppliers. They are applied in areas such as cryopreservation, cryosurgery, medical laboratories, pharmaceutical processes, and dermatological treatments. End users include hospitals and clinics, biotechnology and pharmaceutical companies, research laboratories, and other healthcare facilities.
The medical grade liquid nitrogen market consists of sales of products such as cryogenic storage tanks, liquid nitrogen dewars, delivery systems, and associated safety equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Medical Grade Liquid Nitrogen Market Characteristics
3. Medical Grade Liquid Nitrogen Market Supply Chain Analysis
4. Global Medical Grade Liquid Nitrogen Market Trends and Strategies
5. Medical Grade Liquid Nitrogen Market Analysis of End Use Industries
7. Global Medical Grade Liquid Nitrogen Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Medical Grade Liquid Nitrogen Total Addressable Market (TAM) Analysis for the Market
9. Medical Grade Liquid Nitrogen Market Segmentation
10. Medical Grade Liquid Nitrogen Market Regional and Country Analysis
11. Asia-Pacific Medical Grade Liquid Nitrogen Market
12. China Medical Grade Liquid Nitrogen Market
13. India Medical Grade Liquid Nitrogen Market
14. Japan Medical Grade Liquid Nitrogen Market
15. Australia Medical Grade Liquid Nitrogen Market
16. Indonesia Medical Grade Liquid Nitrogen Market
17. South Korea Medical Grade Liquid Nitrogen Market
18. Taiwan Medical Grade Liquid Nitrogen Market
19. South East Asia Medical Grade Liquid Nitrogen Market
20. Western Europe Medical Grade Liquid Nitrogen Market
21. UK Medical Grade Liquid Nitrogen Market
22. Germany Medical Grade Liquid Nitrogen Market
23. France Medical Grade Liquid Nitrogen Market
24. Italy Medical Grade Liquid Nitrogen Market
25. Spain Medical Grade Liquid Nitrogen Market
26. Eastern Europe Medical Grade Liquid Nitrogen Market
27. Russia Medical Grade Liquid Nitrogen Market
28. North America Medical Grade Liquid Nitrogen Market
29. USA Medical Grade Liquid Nitrogen Market
30. Canada Medical Grade Liquid Nitrogen Market
31. South America Medical Grade Liquid Nitrogen Market
32. Brazil Medical Grade Liquid Nitrogen Market
33. Middle East Medical Grade Liquid Nitrogen Market
34. Africa Medical Grade Liquid Nitrogen Market
36. Medical Grade Liquid Nitrogen Market Competitive Landscape and Company Profiles
37. Medical Grade Liquid Nitrogen Market Other Major and Innovative Companies
40. Medical Grade Liquid Nitrogen Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Medical Grade Liquid Nitrogen Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses medical grade liquid nitrogen market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for medical grade liquid nitrogen? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical grade liquid nitrogen market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Below 99%; 99%-99.9%; Above 99.9%2) By Container Type: Dewar Flasks; Pressurized Cylinders; Storage Tanks; Portable Cryogenic Containers; Bulk Liquid Nitrogen Tanks
3) By Distribution Channel: Direct Sales; Online Sales; Medical Supply Distributors; Retail Pharmacies; Specialty Medical Suppliers
4) By Application Area: Cryopreservation; Cryosurgery; Medical Laboratories; Pharmaceutical Applications; Dermatological Uses
5) By End-User: Hospitals And Clinics; Biotechnology And Pharmaceutical Companies; Research Laboratories; Other End-Users
Subsegments:
1) By Below 99%: Industrial Grade Liquid Nitrogen; Food Grade Liquid Nitrogen; Laboratory Grade (Low Purity) Liquid Nitrogen2) By 99%-99.9%: Research Grade Liquid Nitrogen; Pharmaceutical Support Grade Liquid Nitrogen; Semi-Medical Grade Liquid Nitrogen
3) By Above 99.9%: High-Purity Medical Grade Liquid Nitrogen; Ultra-High Purity Cryogenic Liquid Nitrogen; Electronic And Biotech Grade Liquid Nitrogen
Companies Mentioned: Linde Gas & Equipment Inc.; Air Liquide Healthcare; Air Products and Chemicals Inc.; Airgas Inc.; Nippon Sanso Holdings Corporation; Matheson Tri-Gas Inc.; Gruppo SIAD; Gulf Cryo; AMCS Corporation; Red Ball Oxygen; MVS Engineering Pvt. Ltd.; Coregas Pty Ltd.; Kansal Industrial Gases; Stirling Cryogenics; CalOx Inc.; US Gas; N-Two Medical Inc.; Nitrogen Express; Cryogen (part of the Antares Alliance); Abhijit Enterprises
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Medical Grade Liquid Nitrogen market report include:- Linde Gas & Equipment Inc.
- Air Liquide Healthcare
- Air Products and Chemicals Inc.
- Airgas Inc.
- Nippon Sanso Holdings Corporation
- Matheson Tri-Gas Inc.
- Gruppo SIAD
- Gulf Cryo
- AMCS Corporation
- Red Ball Oxygen
- MVS Engineering Pvt. Ltd.
- Coregas Pty Ltd.
- Kansal Industrial Gases
- Stirling Cryogenics
- CalOx Inc.
- US Gas
- N-Two Medical Inc.
- Nitrogen Express
- Cryogen (part of the Antares Alliance)
- Abhijit Enterprises
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.64 Billion |
| Forecasted Market Value ( USD | $ 3.39 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
